Digoxin use is associated with increased risk of stroke in patients with non-valvular atrial fibrillation--a nationwide population-based cohort study

Int J Cardiol. 2013 Oct 30;169(2):e26-7. doi: 10.1016/j.ijcard.2013.08.103. Epub 2013 Sep 8.

Authors

Shih-Sheng Chang¹, Kuan-Cheng Chang, Yu-Chen Wang, Chih-Hsin Muo, Pei-Ying Pai, Chi-Bin Chang, Chi-Yuan Li, Fung-Chang Sung

Affiliation

¹ Division of Cardiology, Department of Medicine, China Medical University Hospital, Taichung, Taiwan; Graduate Institute of Clinical Medical Science, China Medical University, Taichung, Taiwan.

PMID: 24063919
DOI: 10.1016/j.ijcard.2013.08.103

No abstract available

Keywords: Atrial fibrillation; Digoxin; Platelet activation; Stroke.

Publication types

Letter
Randomized Controlled Trial
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Anti-Arrhythmia Agents / adverse effects*
Anti-Arrhythmia Agents / blood
Atrial Fibrillation / blood
Atrial Fibrillation / drug therapy*
Atrial Fibrillation / epidemiology
Cohort Studies
Digoxin / adverse effects*
Digoxin / blood
Female
Follow-Up Studies
Humans
Longitudinal Studies
Male
Middle Aged
Population Surveillance* / methods
Risk Factors
Stroke / blood
Stroke / chemically induced*
Stroke / epidemiology

Substances

Anti-Arrhythmia Agents
Digoxin